Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control

被引:2
|
作者
Miller, Rachel G. [1 ]
Costacou, Tina [1 ]
机构
[1] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, 130 N Bellefield Ave, Pittsburgh, PA 15213 USA
关键词
Type; 1; diabetes; Cardiovascular disease; Risk factors; Sex differences; Glycemic control; Clinical targets; CORONARY-ARTERY-DISEASE; HAPTOGLOBIN; 2-2; GENOTYPE; C-REACTIVE PROTEIN; RISK-FACTORS; PITTSBURGH EPIDEMIOLOGY; HEART-DISEASE; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; DNA METHYLATION;
D O I
10.1007/s11886-022-01763-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Despite improvements in treatment, people with type 1 diabetes continue to have increased cardiovascular disease (CVD) risk. Glycemic control does not fully explain this excess CVD risk, so a greater understanding of other risk factors is needed. Recent Findings The authors review the relationship between glycemia and CVD risk in adults with type 1 diabetes and summarize evidence regarding other factors that may explain risk beyond glycemia. Insulin resistance, weight gain, sex differences, genetics, inflammation, emerging markers of risk, including lipid subclasses and epigenetic modifications, and future directions are discussed. As glycemic control improves, an increased focus on other CVD risk factors is warranted in type 1 diabetes. Novel markers and precision medicine approaches may improve CVD prediction, but a lack of type 1 diabetes-specific guidelines for lipids, blood pressure, and physical activity are likely impediments to optimal CVD prevention in this high-risk population.
引用
收藏
页码:1467 / 1475
页数:9
相关论文
共 50 条
  • [1] Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control
    Rachel G. Miller
    Tina Costacou
    Current Cardiology Reports, 2022, 24 : 1467 - 1475
  • [2] Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease
    Monteiro, Pedro
    Aguiar, Carlos
    Matos, Pedro
    Silva-Nunes, Jose
    Birne, Rita
    Branco, Patricia
    Calado, Joaquim
    Melo, Miguel
    Polonia, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (10) : 721 - 735
  • [3] Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications
    Bakker, Sjoerd F.
    Tushuizen, Maarten E.
    von Blomberg, Mary E.
    Mulder, Chris J.
    Simsek, Suat
    ACTA DIABETOLOGICA, 2013, 50 (03) : 319 - 324
  • [4] Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications
    Sjoerd F. Bakker
    Maarten E. Tushuizen
    Mary E. von Blomberg
    Chris J. Mulder
    Suat Simsek
    Acta Diabetologica, 2013, 50 : 319 - 324
  • [5] Glycemic control to prevent cardiovascular disease in type 2 diabetes
    Adler A.
    Current Cardiovascular Risk Reports, 2008, 2 (1) : 66 - 71
  • [6] Glycemic control and cardiovascular disease in Type 2 diabetes: a review
    Wild, SH
    Dunn, CJ
    McKeigue, PM
    Comte, S
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (03) : 197 - 204
  • [7] Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes
    Teleb, Mohamed
    Switzer, Maryna Popp
    Elhanafi, Sherif
    Elfar, Ahmed
    San Juan, Zinnia T.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (03) : 1 - 5
  • [8] Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes
    Mohamed Teleb
    Maryna Popp Switzer
    Sherif Elhanafi
    Ahmed Elfar
    Zinnia T. San Juan
    Current Cardiology Reports, 2016, 18
  • [9] Carbohydrate Counting in Type 1 Diabetes: Look Beyond Glycemic Control
    Bhriguvanshi, Arpita
    Bajpai, Anurag
    INDIAN JOURNAL OF PEDIATRICS, 2024, : 1225 - 1226
  • [10] Diabetes and cardiovascular disease: The role of glycemic control
    Cheng, Alice Y. Y.
    Leiter, Lawrence A.
    CURRENT DIABETES REPORTS, 2009, 9 (01) : 65 - 72